Metraipolis › archive › dc_6bed548bf98f

Efficacy and safety analysis of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors with or without… — Europe PMC PMID:41041317

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41041317
DOI: 10.3389/fimmu.2025.1639515
License (as archived): solo-consultazione
Archived: 2026-11-09T22:10:15.861Z
SHA-256 of the archived text: 9098afa3199fa370f06f1c9e47fb393daa1434920eccbf6eb4cd0a78eb977746
Stable URL of this page: https://metraipolis.com/documento/dc_6bed548bf98f

How to cite

Efficacy and safety analysis of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors with or without… — Europe PMC PMID:41041317 — Europe PMC (en), https://europepmc.org/article/MED/41041317 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6bed548bf98f (Metraipolis archive dc_6bed548bf98f, sha256 9098afa3199fa370f06f1c9e47fb393daa1434920eccbf6eb4cd0a78eb977746)

BibTeX

@misc{dc6bed548bf98f,
  title = {Efficacy and safety analysis of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors with or without… — Europe PMC PMID:41041317},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41041317},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6bed548bf98f; sha256 9098afa3199fa370f06f1c9e47fb393daa1434920eccbf6eb4cd0a78eb977746},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041317. Agents can read the archived copy with the MCP tool read_document.